The long-term follow-up of patients with endoscopically diagnosed reflux oesophagitis with specific emphasis to complaints

被引:6
|
作者
Loffeld, Susan M. L. A. [2 ]
Dackus, Gwen M. H. E. [2 ]
Loffeld, Ruud J. L. F. [1 ]
机构
[1] Med Ctr, Dept Internal Med Zaans, Zaandam, Netherlands
[2] Univ Maastricht, Zaandam, Netherlands
关键词
gastroesophageal reflux disease; long-term treatment; proton pump inhibitor; reflux oesophagitis; treatment; RELAPSE; EFFICACY; THERAPY; DISEASE; SAFETY;
D O I
10.1097/MEG.0b013e32834b8d18
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction Patients with gastroesophageal reflux disease (GERD) need long-term treatment with acid-suppressive therapy. Data on long-term follow-up are very rare. For this reason, a study was performed to detect complaints many years after diagnosis. Patients and methods All patients diagnosed with reflux oesophagitis in the years 1998-2000 were included. In the summer of 2010, they received a questionnaire with four different lists of questions pertaining to reflux complaints and use of medication. Severity and frequency were scored on 5-point and 6-point Likert scales, respectively; the GerdQ, a symptom activity index, and the gastrointestinal symptom-rating scale were also used. Results Complaints were reported by 130 patients (63%); the majority of these, 115 (88%), used acid suppressive therapy. Only 78 patients were in clinical remission, with or without therapy. The respondents with complaints were divided into two groups. Group 1: all patients with reflux complaints using acid suppressive therapy. Group 2: all patients with complaints without medication. Patients in group 1 were significantly older at the time of the endoscopic diagnosis compared with patients of group 2, and patients in group 1 had a hiatal hernia more often (P < 0.001). There was no difference in the overall symptom or the frequency score per patient between both groups, with a mean of 5.97 versus 6.8 and 13.4 versus 13.8 respectively. However, heartburn, nausea, acid regurgitation, epigastric pain, dysphagia and nocturnal complaints showed a significantly higher prevalence in patients of group 2. Scores for specific complaints were significantly lower in group 2 and there was no difference between the GerdQ, the symptom activity index and the gastrointestinal symptom-rating scale. Conclusion Despite effective therapy, only 37% of the patients are in complete remission. However, the individual symptom score is rather low. Patients without medication more often have reflux complaints but lower severity scores. Patients who still had complaints and used medication had a hiatal hernia significantly more often. Eur J Gastroenterol Hepatol 23:1122-1126 (C) 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.
引用
收藏
页码:1122 / 1126
页数:5
相关论文
共 50 条
  • [11] Long-term follow-up evaluation for a canine model of gastroesophageal reflux disease
    Jacob, BP
    Dakin, G
    Divino, C
    Kim, W
    Gagner, M
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2003, 17 (02): : 354 - 354
  • [12] Long-term follow up in patients with gastroesophageal reflux disease with specific emphasis on reflux symptoms, use of anti-reflux medication and anti-reflux surgery outcome: a retrospective study
    Van Meer, Suzanne
    Bogte, Auke
    Siersema, Peter D.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2013, 48 (11) : 1242 - 1248
  • [13] Severity of Diverticulitis Does Not Influence Abdominal Complaints during Long-Term Follow-Up
    Ditzel, Max
    Vennix, Sandra
    Menon, Anand G.
    Verbeek, Paul C. M.
    Bemelman, Willem A.
    Lange, Johan F.
    DIGESTIVE SURGERY, 2019, 36 (02) : 129 - 136
  • [14] Clinical presentation and long-term follow-up of perimyocarditis
    Buiatti, Alessandra
    Merlo, Marco
    Pinamonti, Bruno
    De Biasio, Marzia
    Bussani, Rossana
    Sinagra, Gianfranco
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 (03) : 235 - 241
  • [15] Rituximab for minimal change disease in adults: long-term follow-up
    Bruchfeld, Annette
    Benedek, Samiha
    Hilderman, Marie
    Medin, Charlotte
    Snaedal-Jonsdottir, Sunna
    Korkeila, Maarit
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (04) : 851 - 856
  • [16] Long-term follow-up of patients with refractory systemic lupus erythematosus during rituximab treatment
    Tsanyan, M. E.
    Soloviev, S. K.
    Torgashina, A. V.
    Aleksandrova, E. N.
    Radenska-Lopovok, S. G.
    Nikolaeva, E. V.
    Khrennikov, Ya. B.
    Nasonov, E. L.
    TERAPEVTICHESKII ARKHIV, 2014, 86 (05) : 40 - 49
  • [17] Long-Term, Clinical Follow-Up in Fatty Liver Patients
    Bendtsen, Flemming
    Dam-Larsen, Sanne
    DIGESTIVE DISEASES, 2010, 28 (06) : 709 - 714
  • [18] Long-Term Follow-up of Onychomycosis Patients Treated With Efinaconazole
    Pollak, Richard A.
    Ilie, Carla
    JOURNAL OF DRUGS IN DERMATOLOGY, 2017, 16 (12) : 1269 - 1273
  • [19] Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
    Rafiq, Nila
    Bai, Chunhong
    Fang, Yun
    Srishord, Manirath
    McCullough, Arthur
    Gramlich, Terry
    Younossi, Zobair M.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (02) : 234 - 238
  • [20] Long-Term Follow-Up of 4 Patients with Conjunctival Amyloidosis
    Prager, Alisa J.
    Habib, Larissa A.
    Gambogi, Talita
    Busam, Klaus J.
    Marr, Brian P.
    OCULAR ONCOLOGY AND PATHOLOGY, 2018, 4 (05) : 313 - 317